#EFIB2021: Industrial Biotechnology in the business spotlight for EU Green Deal

PRESS RELEASE
This year’s Conference, under the theme ‘Delivering the EU Green Deal: Industrial biotechnology into business’ will focus on how the sector can contribute to transforming the EU into a modern, resource-efficient and competitive economy.
’We are delighted that, after the Digital EFIB edition last year, we are able to invite participants to Vienna to discuss the contribution of industrial biotechnology in addressing societal and environmental challenges and realise its full potential in providing innovative solutions. We are celebrating the ability to do this in person, to meet, network and be together again’, says Dr Claire Skentelbery, Director General of EuropaBio.
EuropaBio is also proud to announce that an EFIB Vienna Statement - a vision document for Industrial Biotechnology will be launched at EFIB this year. An Executive Round table will finalise and present the Business vision for Europe from Industrial Biotechnology, setting yearly goals for policy and regulation to ensure that we can deliver Green Deal ambitions.
This year’s agenda will amongst +60 speakers will feature Anne Bogdanski, from Joint FAO/IAEA Centre and Kristin Schreiber Director, Directorate General for Internal Market, Industry and Entrepreneurship and SMEs, DG Grow, European Commission. Other speakers will include leading executives from companies such as Corbion, DSM, Cargill, Lenzing and others.
EFIB participants will also have the chance to meet with 20 local and international start-ups, learn about recent projects in the industrial biotechnology field at the dedicated poster presentation area and set up business meetings via EFIB Partnering tool.
EFIB delegates will have the opportunity to select the most influential advance from the industrial biotechnology and bioeconomy stories from the 25th EuropaBio anniversary programme. The winner will be announced in the EFIB Final plenary session, followed by the selection of the best Poster presentation at the Closing Session.